DUBLIN--(BUSINESS WIRE)--The "Global Women's Health Therapeutics Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.
The women's health therapeutics market is poised to grow by $30.35 bn during 2022-2026, accelerating at a CAGR of 5.74%
This study identifies the rising awareness of gynecological diseases as one of the prime reasons driving the women's health therapeutics market growth during the next few years. Also, the emergence of novel therapies and rising government initiatives for antibiotic resistance will lead to sizable demand in the market.
The report on the women's health therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strategic alliances.
The women's health therapeutics market analysis includes the type segment and geographic landscape. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading women's health therapeutics market vendors.
Also, the women's health therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
Market Positioning of Vendors
- Abbott Laboratories
- AbbVie Inc.
- Amgen Inc.
- Bayer AG
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GLS Pharma Pvt. Ltd.
- ICON plc
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- ObsEva SA
- Pfizer Inc.
- Radius Health Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- TSUMURA and Co.
- Vivesto AB
- Mithra Pharmaceuticals SA
Key Topics Covered:
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
4 Five Forces Analysis
4.1 Five forces summary
4.2 Bargaining power of buyers
4.3 Bargaining power of suppliers
4.4 Threat of new entrants
4.5 Threat of substitutes
4.6 Threat of rivalry
4.7 Market condition
5 Market Segmentation by Type
5.1 Market segments
5.2 Comparison by Type
5.3 Fertility - Market size and forecast 2021-2026
5.4 Oncology - Market size and forecast 2021-2026
5.5 Menopause - Market size and forecast 2021-2026
5.6 Infection - Market size and forecast 2021-2026
5.7 Others - Market size and forecast 2021-2026
5.8 Market opportunity by Type
6 Customer Landscape
6.1 Customer landscape overview
7 Geographic Landscape
7.1 Geographic segmentation
7.2 Geographic comparison
7.3 North America - Market size and forecast 2021-2026
7.4 Europe - Market size and forecast 2021-2026
7.5 Asia - Market size and forecast 2021-2026
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
7.7 US - Market size and forecast 2021-2026
7.8 Germany - Market size and forecast 2021-2026
7.9 UK - Market size and forecast 2021-2026
7.10 China - Market size and forecast 2021-2026
7.11 Canada - Market size and forecast 2021-2026
7.12 Market opportunity By Geographical Landscape
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
9.3 Landscape disruption
9.4 Industry risks
10 Vendor Analysis
10.1 Vendors covered
10.2 Market positioning of vendors
For more information about this report visit https://www.researchandmarkets.com/r/b3lp5s
